Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities.

Basic Information

Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company headquartered in Hyderabad, engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. The company has been responsible for developing an eco-friendly recombinant and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC. They were one of the first to develop vaccines for viral diseases like Chikungunya and Zika. The company also produces vaccines for Japanese Encephalitis. In April 2020, the company announced that they have partnered with US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. See more

Legal Name

:

Bharat Biotech Ltd.

Headquarters

:

Hyderabad, Telangana, India

Founding Date

:

1996

No. of Employees

:

1000+

Core Team

:
1.

Krishna M Ella

Co-Founder, Chairman & MD

2.

Suchitra Ella

Co-Founder & Director

Funding

Total Funding

$14.1M

Investors

:

1.

CEPI

2.

Subhkam Ventures